Tenaya Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $1,110 | $225 | $0 | $0 |
Gross Profit | 1,110 | -1,538 | 3,948 | -1,864 |
EBITDA | -41,693 | -17,509 | -18,348 | -18,411 |
EBIT | -43,393 | -19,272 | -20,175 | -20,275 |
Net Income | -43,393 | -19,272 | -20,175 | -20,275 |
Net Change In Cash | 1,110 | 225 | 0 | 0 |
Free Cash Flow | -22,956 | -19,245 | -14,007 | -15,625 |
Cash | 78,085 | 80,887 | 100,547 | 56,312 |
Basic Shares | 217,574 | 216,883 | 152,971 | 163,345 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -8,436 | -8,468 | -8,687 | -8,713 |
EBITDA | -82,161 | -102,661 | -115,397 | -119,154 |
EBIT | -90,597 | -111,129 | -124,084 | -125,621 |
Net Income | -90,597 | -111,129 | -124,084 | -123,663 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 56,995 | |||
Free Cash Flow | -68,882 | -91,526 | -103,311 | -125,054 |
Cash | 100,547 | 4,323 | 45,681 | 95,272 |
Basic Shares | 152,971 | 84,822 | 73,786 | 44,823 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.09 |
2026-03-31 | -$0.09 |
2025-12-31 | -$0.12 |
2025-09-30 | -$0.12 |